No Data
The U.S. bioterrorism law has undergone significant changes, the CRO concept has launched a major counterattack, and WuXi AppTec is excited!
Industry pessimistic expectations may improve.
Honkong stock market movement | CRO concept stocks collectively opened higher as the bioprotective legislation was not included in the final version of the NDAA by the U.S. Senate and House of Representatives.
CRO concept stocks opened higher collectively. As of the time of writing, wuxi bio (02269) increased by 13.03%, trading at 19.6 Hong Kong dollars; wuxi apptec (02359) rose by 11.72%, trading at 61 Hong Kong dollars; pharmaron (03759) climbed by 9.14%, trading at 16 Hong Kong dollars.
How to break through the challenges in the development of innovative drugs? The industry suggests focusing on internationalization.
① The year 2024 will be the inaugural year of large-scale authorized trade, and going abroad has become an important direction for the development of local pharmaceutical companies; ② Chinese企业品牌, clinical trial capabilities, data presentation formats, and levels of international operation still need time and practical verification.
Hong Kong stocks unusual movement | CRO concept stocks expanded their gains, wuxi apptec (02359) surged 12% at one point. It is rumored that US legislators are considering making changes to the bioterrorism law.
CRO concept stocks further expanded their gains. As of the time of publication, wuxi apptec (02359) rose by 10%, trading at 55 Hong Kong dollars; pharmaron (03759) increased by 8.12%, trading at 14.64 Hong Kong dollars; wuxi bio (02269) went up by 7.02%, trading at 17.6 Hong Kong dollars.
Hong Kong stock abnormal | CRO concept stocks rebounded in the morning, overseas investment and financing gradually recovered. The pharmaceutical subdivision field and emerging businesses are expected to develop rapidly.
Concept stocks of CRO rebounded in early trading. As of the time of writing, Genscript Bio (01548) rose by 4.39% to HK$10.94; Tigermed (03347) rose by 4.47% to HK$33.85; Frontage (01521) rose by 2.75% to HK$1.12; Joinn Laboratories (06127) rose by 2.49% to HK$9.47; Wuxi Bio (02269) rose by 1.68% to HK$14.54.
Joinn Laboratories(China)Co.Ltd (SHSE:603127 Shareholders Incur Further Losses as Stock Declines 3.8% This Week, Taking Three-year Losses to 75%
Earnings Working Against Joinn Laboratories(China)Co.,Ltd.'s (SHSE:603127) Share Price
No Data
